Updated hourlyHourly refreshTue, Oct 27, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare · Biotech & pharma
Research Letter Reports First-in-Human Use of Circular RNA Therapy, with RXRG001 Demonstrating Durable Improvements in Salivary Flow and Patient-Reported Xerostomia Symptoms Single-Dose Treatment Was Well Tolerated with No Dose-Limiting Toxicities Observed in the First Six Patients Across Two Dose Cohorts RXRG001 Recently
Oct 22 · 12:00·Business Wire
SaaS
Integration of SEEQC's chip-based pre-decoder architecture with NVIDIA Ising, leveraging the all-digital interface of SEEQC's Digital Link with NVIDIA NVQLink, delivers approximately 50% improvement in key decoding performance metrics ELMSFORD, N.Y. & SANTA CLARA, Calif., October 22, 2026--SEEQC , Inc
Oct 22 · 12:00·Business Wire
Crypto · Cybersecurity
Panel of Expert Judges Recognizes QuSecure's Crypto-agile Control Plane that Finds and Fixes Vulnerable Cryptography with No Rip and Replace SAN MATEO, Calif., October 22, 2026--QuSecure™, Inc., a crypto-agile infrastructure provider and leader in post-quantum cryptography (PQC) , today announced it ha
Oct 22 · 12:00·Business Wire
Finance · Biotech & pharma
Conference call and audio webcast to be held at 8:30 a.m. ET CHICAGO, October 22, 2026--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a leading, endocrine and rare disease biopharmaceutical company committed to helping people realize better lives through the development and commercialization of innova
Oct 22 · 12:00·Business Wire
Healthcare · Jobs & workplace
Investment will help strengthen OB-GYN coverage, recruit maternal health providers and advance a rural family medicine with obstetrics workforce pipeline October 22, 2026--UnitedHealthcare today announced a $540,000 investment to support Northeast Missouri Health Council (NMHC), a federally qualified h
Oct 22 · 12:00·Business Wire
AI
New AI-powered cobot system makes real-time welding decisions, adapts to changing joint conditions and designed to learn from every weld. NORTH BETHESDA, Md., October 22, 2026--ESAB introduces ROBBI AI™, a new cobot system that uses physical artificial intelligence (AI) to sense and respond to real-wor
Oct 22 · 12:00·Business Wire
Finance
BIRMINGHAM, Ala., October 22, 2026--MPT (the "Company" or "MPT") (NYSE: MPT) today announced it will host a conference call and webcast on Thursday, October 29, 2026, at 11:00 a.m. Eastern Time to discuss the Company's third quarter 2026 financial results. A press release with the third quarter 2026 fi
Oct 22 · 12:00·Business Wire
Biotech & pharma
GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term payments, as part of a total deal value of up to $1.1 billion, plus royalties. FLORENCE, Italy & GAITHERSBURG, Md., October 2
Oct 22 · 12:00·Business Wire
Retail · Travel
American Express and Airbnb Launch Exclusive Partnership Eligible Card Members can earn Membership Rewards ® points when booking with Airbnb through Amex Travel online with additional benefits available for U.S. Consumer and Business Platinum Card ® Members for eligible Airbnb Luxe bookings NEW YORK & SAN FRANCISCO, Octob
Oct 22 · 12:00·Business Wire
Finance · Biotech & pharma
BEDFORD, Mass., October 22, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential diseas
Oct 22 · 12:00·Business Wire
Finance · Healthcare
Independent Data Safety Monitoring Board to Conduct a Pre-Specified Interim Analysis to Assess Need for Sample Size Re-Estimation Interim Analysis Results Expected in Q1 2027 MINNEAPOLIS, October 22, 2026--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on
Oct 22 · 12:00·Business Wire
Finance
NEW YORK, October 22, 2026--Western Asset Managed Municipals Fund Inc. (the "Fund") (NYSE: MMU) announced today the results of the votes cast at the Fund's annual meeting of stockholders held October 16, 2026. Robert D. Agdern, Peter Mason and Jane Trust were elected as a Class III Directors of the Fun
Oct 22 · 12:00·Business Wire